| MYCOF Stock | | | USD 0 0.0002 5.00% |
Mydecine Innovations Group
fundamentals help investors to digest information that contributes to Mydecine Innovations' financial success or failures. It also enables traders to predict the movement of Mydecine Pink Sheet. The
fundamental analysis module provides a way to measure
Mydecine Innovations' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various
microeconomic indicators and financial ratios related to Mydecine Innovations pink sheet.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to
Equity Screeners to view more equity screening tools.
Mydecine Innovations Group Company Number Of Shares Shorted Analysis
Mydecine Innovations' Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
Based on the recorded statements, Mydecine Innovations Group has 0.0 of outstending shares currently sold short by investors. This is 100.0% lower than that of the Healthcare sector and about the same as
Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. The number of shares shorted for all United States stocks is 100.0% higher than that of the company.
| | Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
Mydecine Fundamentals
About Mydecine Innovations Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mydecine Innovations Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mydecine Innovations using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at
the intrinsic value of Mydecine Innovations Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing
financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Currently Active Assets on Macroaxis
Other Information on Investing in Mydecine Pink Sheet
Mydecine Innovations financial ratios help investors to determine whether Mydecine Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mydecine with respect to the benefits of owning Mydecine Innovations security.